A detailed history of Cannell & Co. transactions in Medtronic PLC stock. As of the latest transaction made, Cannell & Co. holds 22,800 shares of MDT stock, worth $1.85 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
22,800
Previous 22,800 -0.0%
Holding current value
$1.85 Million
Previous $1.79 Million 5.15%
% of portfolio
0.06%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023

SELL
$76.72 - $87.58 $30,688 - $35,032
-400 Reduced 1.72%
22,800 $1.84 Million
Q2 2022

Aug 08, 2022

SELL
$87.4 - $113.09 $768,595 - $994,513
-8,794 Reduced 27.49%
23,200 $2.08 Million
Q1 2022

May 10, 2022

SELL
$100.58 - $112.38 $206,591 - $230,828
-2,054 Reduced 6.03%
31,994 $3.55 Million
Q4 2021

Feb 09, 2022

SELL
$99.53 - $127.75 $19,906 - $25,550
-200 Reduced 0.58%
34,048 $3.52 Million
Q1 2020

May 05, 2020

SELL
$72.92 - $121.3 $51,044 - $84,910
-700 Reduced 2.0%
34,248 $3.09 Million
Q3 2019

Nov 12, 2019

SELL
$98.02 - $111.18 $172,025 - $195,120
-1,755 Reduced 4.78%
34,948 $3.8 Million
Q2 2019

Aug 12, 2019

SELL
$84.15 - $99.38 $105,524 - $124,622
-1,254 Reduced 3.3%
36,703 $3.58 Million
Q1 2019

May 14, 2019

SELL
$82.45 - $93.79 $29,846 - $33,951
-362 Reduced 0.94%
37,957 $3.46 Million
Q4 2018

Feb 11, 2019

BUY
$85.8 - $99.49 $85 - $99
1 Added 0.0%
38,319 $3.49 Million
Q2 2018

Aug 06, 2018

SELL
$77.48 - $87.83 $30,992 - $35,132
-400 Reduced 1.03%
38,318 $3.28 Million
Q1 2018

May 09, 2018

SELL
$76.55 - $87.26 $114,825 - $130,890
-1,500 Reduced 3.73%
38,718 $3.11 Million
Q4 2017

Feb 13, 2018

SELL
$76.93 - $83.5 $114,702 - $124,498
-1,491 Reduced 3.57%
40,218 $3.25 Million
Q3 2017

Nov 08, 2017

BUY
$77.71 - $84.6 $3.24 Million - $3.53 Million
41,709
41,709 $3.24 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Cannell & Co. Portfolio

Follow Cannell & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.